Wang 2008

Methods	Women randomly allocated to 2 groups. Method of randomisation not reported
Participants	100 women attending in an obs/gyn clinic, No. 5 hospital, Haerbin Medical University, China. Women had regular menstrual periods and a single act of unprotected intercourse within 72 h of attending the clinic
Interventions	Mife 25 mg vs Mife 10 mg, single dose, orally
Outcomes	Observed number of pregnancies, side effects and changes in menstrual pattern
Notes	Observed pregnancy/total number of women: Mife 25 mg 1/50; Mife 10 mg 1/50 Side effects: Mife 25 mg: nausea and vomiting 3/50; dizziness 2/50; breast tenderness 1/50; fatigue 2/50; diarrhoea 3/50 Mife 10 mg: nausea and vomiting 2/50; dizziness 1/50; breast tenderness 1/50; fatigue 2/50; diarrhoea 2/50 Changes in menstrual pattern:  Early: Mife 25 mg 1/49; Mife 10 mg 1/49 Delay: Mife 25 mg 6/49; Mife 10 mg 5/49 Spotting: Mife 25 mg 1/49; Mife 10 mg 1/49
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Mentioned randomisation but description not adequate
Allocation concealment (selection bias)	Unclear risk	Method of allocation concealment not mentioned
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Not mentioned
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	No mention of post‐randomisation exclusion and loss to follow‐up
Selective reporting (reporting bias)	Low risk	Reported planned outcomes
Other bias	Low risk	None detected